CATHERINE C. TURKEL
CIK 1705278 · President · last filed 2024-08-13
CATHERINE C. TURKEL is a President who has filed 17 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing shows the insider bought $5.0K of LEXXW on Aug 13, 2024. Across all open-market trades the lifetime net is +$266.0K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
17
$266.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Lexaria Bioscience Corp. (LEXXW) Delisted | Director | 1,500 | $0.00 | $2 | $9.3K | 7 | 2024-08-13 |
| Eledon Pharmaceuticals, Inc. (NVUS) Delisted | President | 91,381 | — | — | $145.7K | 9 | 2020-03-20 |
| Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Chief Development Officer | 24,519 | — | — | $111.0K | 1 | 2017-05-11 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-13 | Lexaria Bioscience Corp. (LEXXW) Delisted | Buy (P) | +1,600 | $5.0K | EDGAR |
| 2024-07-30 | Lexaria Bioscience Corp. (LEXXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-10 | Lexaria Bioscience Corp. (LEXXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-07-25 | Lexaria Bioscience Corp. (LEXXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-27 | Lexaria Bioscience Corp. (LEXXW) Delisted | Buy (P) | +1,500 | $4.3K | EDGAR |
| 2022-10-13 | Lexaria Bioscience Corp. (LEXXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-09-06 | Lexaria Bioscience Corp. (LEXXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-20 | Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-09-30 | Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-22 | Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Sell (S) | −9,537 | -$18.6K | EDGAR |